| 000 | 01927 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514205523.0 | ||
| 264 | 0 | _c20041202 | |
| 008 | 200412s 0 0 eng d | ||
| 022 | _a0019-9567 | ||
| 024 | 7 |
_a10.1128/IAI.72.11.6622-6632.2004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrandt, Lise | |
| 245 | 0 | 0 |
_aThe protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs. _h[electronic resource] |
| 260 |
_bInfection and immunity _cNov 2004 |
||
| 300 |
_a6622-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBCG Vaccine _xadministration & dosage |
| 650 | 0 | 4 |
_aBacterial Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization, Secondary |
| 650 | 0 | 4 |
_aLung _xpathology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xgenetics |
| 650 | 0 | 4 |
_aPolyproteins _xadministration & dosage |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 |
_aTuberculosis Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xmortality |
| 650 | 0 | 4 | _aVaccination |
| 650 | 0 | 4 |
_aVaccines, Synthetic _ximmunology |
| 700 | 1 | _aSkeiky, Yasir A W | |
| 700 | 1 | _aAlderson, Mark R | |
| 700 | 1 | _aLobet, Yves | |
| 700 | 1 | _aDalemans, Wilfried | |
| 700 | 1 | _aTurner, Oliver C | |
| 700 | 1 | _aBasaraba, Randall J | |
| 700 | 1 | _aIzzo, Angelo A | |
| 700 | 1 | _aLasco, Todd M | |
| 700 | 1 | _aChapman, Philip L | |
| 700 | 1 | _aReed, Steven G | |
| 700 | 1 | _aOrme, Ian M | |
| 773 | 0 |
_tInfection and immunity _gvol. 72 _gno. 11 _gp. 6622-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/IAI.72.11.6622-6632.2004 _zAvailable from publisher's website |
| 999 |
_c15191074 _d15191074 |
||